NCT03144037

Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors

Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors - (AIs)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 152 (actual)
• Sponsor: Texas Tech University Health Sciences Center, El Paso · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is an observational trial designed to assess prospectively the adherence rate to AIs among women with invasive breast cancer (stages I-III) currently receiving AI adjuvant therapy after standard local and systemic therapy. We will study adherence by administrating the 8-item Morisky Medication Adherence Scale (MMAS - 8).

Detailed description

* Women with breast cancer seen at the Texas Tech Physicians Breast Care Center will be recruited during their routine follow-up visit with their medical oncologist. * Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR) invasive breast cancer stages I - III with no evidence of metastatic disease (M0). * Patients must be on one of AI (steroidal or non-steroidal). * Patient must have completed local treatment (surgery /radiation) and recovered from all side effects of chemotherapy and surgery. * Patient must be able to complete a demographic and the MMAS - 8 questionnaires in English or Spanish.

Conditions

• Breast Cancer

Timeline

• Start date: 2017-04-26
• Primary completion: 2021-03-19
• Completion: 2021-03-19
• First posted: 2017-05-08
• Last updated: 2021-03-29

Locations

1 site across 1 country: United States